TET2 and chronic myelomonocytic leukemia: Specifically, single and multiple TET2 mutations were analyzed separately, hypothesizing the presence of a distinct signature derived from the gene dosage effect of TET2 as was observed in chronic myelomonocytic leukemia [34].